Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Mast Therapeutics, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 0.3195||$ 0.599|
|Low||$ 0.29||$ 0.2111|
The current last sale of $0.3009 is 42.54% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases with significant unmet needs. We have built our product pipeline through the strategic acquisition of privately-held companies with clinical-stage assets and we currently are focused on developing new therapies for sickle cell disease, a chronic, genetic disorder classified as a rare, or orphan, disease in the United States and European Union, and for heart failure, a condition with a high unmet need for innovative treatment options. We are leveraging our Molecular Adhesion & Sealant Technology, or MAST, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers, to develop vepoloxamer (also known as MST-188), our lead product candidate. ... More ...
Where does MSTX fit in the risk graph?
|Annual EPS Est:||$-0.25|
|Quarterly EPS Est:||-0.06|